Losartan can cause stomach problems, but the gastrointestinal side effects most people experience are mild and, in controlled trials, show up at roughly the same rate as a sugar pill. Nausea, diarrhea, and general abdominal discomfort are all documented reactions, yet the broader picture is more interesting than that simple list suggests. Some of the digestive complaints people attribute to losartan may actually stem from the inactive ingredients in their tablets, and in rare cases, a more serious gut condition can develop that mimics celiac disease.
How Common Are GI Side Effects With Losartan
Losartan belongs to a class of blood pressure drugs called angiotensin II receptor blockers, or ARBs. As a group, these medications have one of the best tolerability profiles among all blood pressure treatments. A systematic review examining adverse reactions across losartan, valsartan, and candesartan found that the most frequently reported events included headache, dizziness, low blood pressure, elevated potassium, nausea, upper respiratory symptoms, and fatigue. The review concluded that these reactions were generally not severe and rarely led people to stop taking the medication.1Pharmacology and Clinical Pharmacy Research. Adverse Drug Reaction of Angiotensin Receptor Blockers (Valsartan, Candesartan, Losartan): a Systematic Review
A broader review of ARBs as a class found that gastrointestinal disturbances, along with dizziness, headache, and cough, occurred at about the same rate as with placebo.2American Journal of Health-System Pharmacy. Angiotensin II-receptor antagonists: An overview That finding is echoed by a pharmacology review of losartan specifically, which noted that dizziness was the only drug-related event reported more frequently with losartan than with placebo in clinical trials.3Drugs. Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension So if you are taking losartan and experiencing mild stomach upset, the drug could be the cause, but statistically, something else in your diet, routine, or health could just as easily explain it.
Nausea Is the Most Reported Stomach Complaint
Among people who do report digestive trouble on losartan, nausea is the single most common complaint. A large pharmacovigilance study that tracked adverse reactions in over 14,500 patients found that nausea was among the most frequently reported adverse drug reactions and among the most common reasons people decided to stop taking the drug.4Journal of Human Hypertension. Losartan: a study of pharmacovigilance data on 14 522 patients That same study listed dizziness, malaise, fatigue, cough, and headache alongside nausea as the top reported events. In other words, nausea was not an outlier. It sat within a cluster of generally mild symptoms that most people tolerated without major disruption.
If you are noticing nausea after starting losartan, the timing matters. Nausea that appears in the first few days or weeks of treatment and then fades is a common pattern with many blood pressure medications, because your body is adjusting to a lower blood pressure set point. Nausea that persists for weeks, worsens over time, or comes with vomiting, weight loss, or severe diarrhea is a different story and warrants a conversation with your doctor.
Chronic Diarrhea and Sprue-Like Enteropathy
The rarest and most serious GI complication linked to losartan is something called sprue-like enteropathy. This condition causes severe, chronic diarrhea along with significant weight loss, and it develops after long-term use of the drug, sometimes months or even years into treatment. A case report in the American Journal of Gastroenterology noted that the infrequency of this reaction makes it difficult to diagnose, because neither the patient nor the clinician tends to suspect a blood pressure pill taken for years as the culprit.5American Journal of Gastroenterology. An Unusual Cause of Diarrhea: Losartan-Induced Sprue-Like Enteropathy
What happens in the gut resembles celiac disease: the tiny finger-like projections lining the small intestine (villi) become flattened or destroyed, which prevents your body from absorbing nutrients properly. A recent case report documented losartan-induced sprue-like enteropathy presenting with isolated villous atrophy in the ileum, the last section of the small intestine, and noted that while olmesartan is the ARB most frequently tied to this condition, cases involving other ARBs including losartan have been increasingly recognized.6PubMed Central. Losartan-Induced Sprue-Like Enteropathy Presenting With Isolated Ileal Villous Atrophy: A Report of a Rare and Atypical Case
To put the rarity in perspective, a systematic review of published case reports found only 2 cases tied to losartan out of 248 total ARB-related sprue-like enteropathy cases. Olmesartan accounted for 233 of those, or about 94%.7Gastroenterology Report. Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review A separate analysis of the FDA’s adverse event database found a similar pattern: out of more than 4,300 ARB-related sprue-like enteropathy reports, about 98% involved olmesartan, with 97 cases spread across all other ARBs combined.8PubMed. Angiotensin Receptor Blocker-Related Sprue-like Enteropathy: Review of Food and Drug Administration Adverse Event Reporting System So while losartan can technically cause this, the risk is vanishingly small compared to olmesartan. If your doctor suspects an ARB is behind unexplained chronic diarrhea and weight loss, switching from olmesartan to losartan (or another ARB) is actually one of the standard approaches.
The Paradox in Animal Research
Here is where the story gets genuinely surprising. While some people report stomach trouble on losartan, a body of animal research suggests the drug may actually protect the stomach lining. In rat studies, blocking the angiotensin II type 1 receptor (the exact receptor losartan targets) increased blood flow to the stomach by 40 to 50% and prevented stress-induced ulcer formation by 70 to 80%. The mechanism involved reduced inflammation, decreased infiltration of immune cells into the stomach wall, and maintained release of protective compounds in the gastric lining.9PubMed. Anti-inflammatory effects of angiotensin II AT1 receptor antagonism prevent stress-induced gastric injury
Another rat study found that losartan increased healing of existing chronic gastric ulcers, reduced gastric acid secretion, and increased the mucin content that coats and protects the stomach.10PubMed. Effect of centrally administered losartan on gastric and duodenal ulcers in rats A third study compared losartan with enalapril (an ACE inhibitor) for stress-induced gastric ulcer protection and found that while both drugs helped, losartan had a slight edge because it additionally boosted the activity of catalase, an antioxidant enzyme in the stomach lining.11International Journal of Basic & Clinical Pharmacology. The role of losartan and enalapril in the protection against stress-induced gastric mucosal ulceration in rats
These findings do not directly contradict the clinical reports of nausea and GI upset, because nausea and stomach-lining protection operate through different pathways. You can feel queasy from a drug that is, at the cellular level, doing beneficial things to your gut tissue. But the research does complicate the narrative. If anything, losartan appears to be gentler on the stomach than many other medications people routinely take for chronic conditions. The most common pain relievers, for instance, actively damage the gastric lining over time. Losartan, at least in animals, does the opposite.
Effects on Gut Bacteria and Intestinal Integrity
Another dimension of losartan’s relationship with the gut involves the microbiome. A study in hypertensive rats found that losartan corrected several markers of gut dysbiosis, restoring the balance between major bacterial groups and increasing levels of beneficial bacteria that produce short-chain fatty acids. Critically, losartan also improved the structural integrity of the colon wall and reduced overactive nerve signaling to the gut. When the researchers compared losartan to hydralazine, another blood-pressure-lowering drug, hydralazine reduced blood pressure just as effectively but did nothing to fix the gut dysbiosis or improve colonic integrity.12PubMed Central. Changes to the gut microbiota induced by losartan contributes to its antihypertensive effects
This is an animal study, so direct translation to humans requires caution. But it raises an intriguing possibility: for people whose high blood pressure is entangled with gut-health disruptions, losartan may address both problems simultaneously. The researchers suggested that part of losartan’s blood-pressure-lowering effect might actually work through the gut, not just through blood vessels. That does not mean losartan is a probiotic or a digestive aid. It does mean that the drug’s interaction with the GI system is more nuanced than a simple side-effects list would suggest.
Why the Gut Can React Even When the Drug Is “Gentle”
A separate line of research sheds light on how losartan interacts with pain and inflammation signaling in the gut. In a study of visceral hypersensitivity (the type of heightened pain sensing that drives conditions like irritable bowel syndrome), losartan reduced the activation of specialized cells in the intestinal lining that amplify pain and inflammatory signals. It lowered levels of multiple inflammatory markers and pain-related chemicals in colon tissue.13Elsevier. Losartan attenuates acetic acid enema-induced visceral hypersensitivity by inhibiting the ACE1/Ang II/AT1 receptor axis in enteric glial cells Again, this is animal data, but it suggests that losartan’s net effect on gut inflammation leans toward calming things down rather than stirring them up.
So why do some people genuinely feel worse in the stomach when they start losartan? A few explanations are plausible. Blood pressure changes themselves can trigger nausea, especially in the first days on a new medication. Some individuals are simply more sensitive to any new compound passing through the GI tract. And there is one underappreciated factor that deserves its own discussion: what else is in the pill.
Generic Tablets and the Excipient Factor
Every pill contains more than its active ingredient. The binders, coatings, fillers, and disintegrants that hold a tablet together and control how it dissolves are called excipients. Most of these are inert for most people. But not always. A review in the European Heart Journal found that certain excipients in generic cardiovascular medications can influence gastrointestinal transit time and drug absorption. Specifically, lactose-based excipients in some generic formulations have been linked to GI disturbances, and surfactants used in tablets can affect how the drug is transported across the gut wall.14Oxford Academic. Low quality of some generic cardiovascular medicinal products represents a matter for growing concern
This matters for losartan because it is one of the most widely prescribed blood pressure medications in the world, and the vast majority of prescriptions are filled with generic versions. If you have noticed that your stomach problems started after switching from one manufacturer’s losartan to another, or after moving from brand-name to generic, the excipients rather than the losartan itself could be the issue. People with lactose intolerance are especially worth flagging here: a lactose-containing filler in a daily medication can cause bloating, gas, and diarrhea that looks exactly like a drug side effect. Asking your pharmacist which excipients are in your specific tablet, or trying a different manufacturer, is a low-cost experiment worth running before abandoning the drug entirely.
Pancreatitis as an Extremely Rare Complication
One more GI-adjacent concern worth mentioning is pancreatitis, inflammation of the pancreas that typically presents as severe upper abdominal pain radiating to the back, along with nausea and vomiting. A published case report documented recurrent pancreatitis attributed to losartan after all other possible causes were excluded through lab work and imaging.15PubMed Central. Losartan-induced Pancreatitis This is genuinely rare, rare enough to warrant a case report rather than a cohort study. But it is worth being aware of because drug-induced pancreatitis is often overlooked when evaluating abdominal pain. If you are on losartan and develop severe, persistent upper abdominal pain, especially with vomiting, your doctor should consider the medication as a potential contributor, even if it has been well tolerated for a long time.
When to Talk to Your Doctor Versus When to Wait It Out
Mild nausea or a slightly off stomach in the first week or two of losartan is common and usually resolves without intervention. Taking the pill with food rather than on an empty stomach helps many people. Staying hydrated matters too, because losartan can mildly increase urination, and dehydration itself causes nausea.
Symptoms that warrant prompt medical attention include:
- Persistent diarrhea: lasting more than a few weeks, especially if watery, voluminous, or accompanied by weight loss
- Severe abdominal pain: particularly upper abdominal pain radiating to the back, which could signal pancreatitis
- Unintended weight loss: even modest amounts over a few months, which could indicate malabsorption from villous atrophy
- Symptoms that appeared after a long stable period: sprue-like enteropathy can develop months or years into treatment, so new-onset diarrhea on a medication you have taken uneventfully for a long time still warrants investigation
The key diagnostic step for sprue-like enteropathy is a small-bowel biopsy showing villous atrophy, combined with negative celiac serology and resolution of symptoms after stopping the ARB. If your doctor is not familiar with this condition, it may be worth mentioning that ARBs are a recognized cause, since the diagnosis is easy to miss.
How Losartan Compares to Other Blood Pressure Drugs for GI Tolerability
Among blood pressure medications as a whole, ARBs including losartan sit near the top for GI tolerability. ACE inhibitors, the closely related class that works on the same hormonal pathway but at a different step, are well known for causing a persistent dry cough in up to 10 to 15% of patients. That cough can itself trigger nausea and a feeling of stomach upset. Calcium channel blockers can cause constipation, particularly verapamil. Beta-blockers sometimes cause nausea, diarrhea, or abdominal cramping. Diuretics alter electrolyte balance in ways that can produce stomach upset and muscle cramps.
Losartan’s profile, where the most common GI event (nausea) appears at rates not significantly different from placebo, is about as good as it gets for a daily medication. If you need blood pressure treatment and have a sensitive stomach, losartan is a reasonable choice. The evidence does not suggest it carries elevated GI risk compared to alternatives. If anything, the animal data on gastric protection and microbiome improvement hint at a uniquely favorable gut profile, though those findings still need human confirmation.
Losartan and Alcohol or NSAID Interactions
Two common substances interact with losartan in ways that can compound stomach problems. Nonsteroidal anti-inflammatory drugs like ibuprofen and naproxen both reduce the blood-pressure-lowering effectiveness of losartan and independently damage the stomach lining. Taking them together puts you at higher risk of GI irritation than either would alone. If you need regular pain relief while on losartan, acetaminophen is generally a safer choice for your stomach and does not interfere with blood pressure control.
Alcohol is the other common factor. Losartan lowers blood pressure, and alcohol does too in the short term. The combination can cause a sharper-than-expected blood pressure drop, which often manifests as dizziness and nausea. If you are newly started on losartan and find that your usual glass of wine leaves you feeling queasy or lightheaded, the interaction is the likely explanation. Reducing alcohol intake, especially in the first weeks of treatment, can make the adjustment period considerably smoother.